Sou Hu Cai Jing·2025-10-30 11:13Group 1 - China Life Insurance (02628.HK) announced plans to invest RMB 2 billion and RMB 10 million in equity investment plans established by Guoshou Investment, with contracts expected to be signed by March 31, 2026 [1] - The investment will primarily focus on sectors such as semiconductors, digital energy, and smart electric vehicles [1] - As of October 30, 2025, China Life's stock closed at HKD 24.72, down 1.28%, with a trading volume of 82.187 million shares and a turnover of HKD 2.058 billion [1] Group 2 - The stock has received a majority "overweight" rating from investment banks, with one bank issuing an overweight rating in the last 90 days and a target average price of HKD 29.5 [1] - The latest report from Xingzheng International gives China Life an overweight rating [1] - China Life's market capitalization in the Hong Kong stock market is HKD 186.327 billion, ranking 5th in the insurance industry [2] Group 3 - Key performance indicators for China Life include a Return on Equity (ROE) of 21.57%, which is significantly higher than the industry average of 13.8%, ranking 2nd in the industry [2] - The company reported operating revenue of HKD 533.88 billion, also above the industry average of HKD 272.89 billion, ranking 4th [2] - The net profit margin stands at 17.52%, slightly above the industry average of 17.41%, ranking 6th [2]